Heart Failure Clinics

Article	Citations
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	62
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	28
Unusual Forms of Pulmonary Hypertension	27
When all Else Fails, Try This	27
Changing Landscape of Heart Failure Imaging	25
Forthcoming Issues	25
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	23
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	20
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	20
Contents	20
Therapy-Related Clonal Hematopoiesis	20
Contributors	19
Contributors	18
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure	17
Genetics of High-Altitude Pulmonary Edema	16
Mitral Regurgitation	16
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	15
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	15
Arrhythmias in Adult Congenital Heart Disease Heart Failure	14
Preload Reduction Therapies in Heart Failure	14
Contributors	13
Contributors	12
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	12
What Is New in Risk Assessment in Nuclear Cardiology?	12
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	12

Myocardial Dysfunction in Patients with Cancer	11
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	11
Arrythmia-Mediated Valvular Heart Disease	11
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	11
Copyright	11
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	10
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	10
Heart Failure Clinics	10
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	10
Coronary Angiography in the Evaluation of Systolic Heart Failure	10
Application of 3D Printing Technology in Heart Failure	9
Cardiac Contractility Modulation	9
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	9
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	8
SGLT2 Inhibitors in Heart Failure	8
Noncoding RNAs in Pulmonary Arterial Hypertension	8
Cardiac Amyloidosis	8
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	8
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	7
Copyright	7
Preface	7
Contents	6
Contents	6
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	6
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	6
Contents	6
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	6
Contributors	6
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	6
Contents	6
Aortic Valvular Stenosis and Heart Failure	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	5
Copyright	5
Contents	5
Adults with Congenital Heart Disease and Transplant	5
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	5
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	4
SGLT2 Inhibitors and Peripheral Vascular Events	4
The Risk of Sudden Unexpected Cardiac Death in Children	4
Clinical Practice Guidelines in Cardio-Oncology	4
Clinical Use of Biomarkers in Cardiac Amyloidosis	4
Advances in the Therapy of Light Chain Cardiac Amyloidosis	4
Remote Monitoring Devices and Heart Failure	4
Coronary Microvascular Dysfunction	4
Pathophysiology of Cardiac Amyloidosis	4
Contributors	3
Forthcoming Issues	3

Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	3
Copyright	3
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification	3
Contributors	3
Contributors	3
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	3
Risk Factors for Progression in Hypertrophic Cardiomyopathy	3
Novel Non-pharmacological Approaches to Heart Failure	3
Latest Updates in Heart Failure Imaging	3
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome	3
Copyright	3
Adult Congenital Heart Disease	2
Epigenetic Regulation in Dilated Cardiomyopathy	2
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification	2
Forthcoming Issues	2
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension	2
Copyright	2
Contents	2
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk	2
Novel Approaches to Sleep Apnea in Heart Failure	2
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease	2
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies	2
Mechanical Circulatory Support in COVID-19	2
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	2
Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome	2
Contents	2
Changing Landscape of Heart Failure Imaging	2
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	2
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All	2
Clinical and Molecular Aspects of Naxos Disease	2
Use and Prognostic Implications of Cardiac Troponin in COVID-19	1
Extracardiac Prothrombotic Effects of COVID-19	1
Multimodality Imaging in Aortic Stenosis	1
Cardiopulmonary Exercise Testing in Research	1
Obesity in Heart Failure with Reduced Ejection Fraction	1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure	1
Challenges in Pulmonary Hypertension	1
Nuclear Cardiology	1
Copyright	1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?	1
Contributors	1
Contributors	1
Contents	1
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension	1
Forthcoming Issues	1
How to Start an Invasive Cardiopulmonary Exercise Testing Program	1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction	1
Radionuclide Assessment of Sarcoidosis	1
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease	1
Contributors	1
Using Artificial Intelligence to Better Predict and Develop Biomarkers	1
Surgical Revascularization Decisions in Ischemia and Heart Failure	1
PET and Cardiac Amyloidosis	1
Translational Research in Cardio-Oncology	1
Challenges in Pulmonary Hypertension	1
Amyloidosis and Amyloidogenesis	1
Novel PET Applications and Radiotracers for Imaging Cardiovascular Pathophysiology	1
Copyright	1
Contributors	1
Contents	1
Radionuclide Imaging of Infective Endocarditis	1
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies	1
Valvular Heart Failure due to Tricuspid Regurgitation	1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction	1
Copyright	0
Genetics in Congenital Heart Diseases	0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events	0
Contents	0
Forthcoming Issues	0
Arrhythmic Stratification of Cardiac Amyloidosis	0
Phenotyping the Many Faces of Hypertrophic Cardiomyopathy	0
Copyright	0
Secondary Mitral Regurgitation and Heart Failure	0
Machine Learning in Cardiovascular Imaging	0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism	0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension	0
Coronary Artery Disease and Heart Failure	0
Forthcoming Issues	0

Contributors	0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity	0
Arrhythmogenic Cardiomyopathy	0
Contents	0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease	0
Contributors	0
Navigating the Evolving Landscape of Hypertrophic Cardiomyopathy	0
Nuclear Cardiology in 2023	0
Heart Failure Preserved Ejection Fraction in Women	0
Forthcoming Issues	0
Contents	0
The War Against Heart Failure Hospitalizations	0
Oxygen Therapy in Pulmonary Vascular Disease	0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	0
Forthcoming Issues	0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis	0
Contributors	0
Contents	0
Cardiopulmonary Exercise Testing in Advanced Heart Failure Management	0
Contents	0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus	0
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care	0
Interventional Approaches to Augment Pharmacotherapy in Heart Failure	0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management	0
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia	0
Forthcoming Issues	0
Renoprotective Effects of SGLT2 Inhibitors	0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects	0
The Pathogenic Role of the DNA Double-Stranded Breaks in Hereditary Cardiomyopathies	0
Pregnancy and Pulmonary Hypertension	0
Forthcoming Issues	0
Cardiovascular Health Care Implications of the COVID-19 pandemic	0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography	0
Valvular Heart Disease and Heart Failure	0
Advances in Single-Photon Emission Computed Tomography	0
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis	0
Contents	0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management	0
Artificial Intelligence and Mechanical Circulatory Support	0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability	0
SGLT2 Inhibitors Are Lifesavers in Heart Failure	0
The Evolving Landscape of Hypertrophic Cardiomyopathy	0
Contents	0
Forthcoming Issues	0
Primary Mitral Regurgitation and Heart Failure	0
Cardiac Amyloidosis	0
Framework for Digital Health Phenotypes in Heart Failure	0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy	0
Spontaneous Coronary Artery Dissection	0
Standard Therapy in Cardiac Amyloidosis	0
Cardiovascular Effects of COVID-19	0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease	0
T-cell Immunotherapy and Cardiovascular Disease	0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease	0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure	0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice	0
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”	0
Covid-19	0
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy	0
SGLT-2 Inhibitors	0
Copyright	0
Training and Career Development in Cardio-Oncology Translational and Implementation Science	0
Exercise Testing in Elite Athletes	0
Contents	0
Stress-First Myocardial Perfusion Imaging	0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction	0
Epidemiology and Definition of Heart Failure in Adult Congenital Heart Disease	0
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure	0
Contributors	0
Radionuclide Imaging of Heart-Brain Connections	0
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis	0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension	0
Copyright	0
Hypertrophic Cardiomyopathy in RASopathies	0
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years	0
Targeted Therapies for Microvascular Disease	0
Copyright	0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension	0
Clinical Manifestations of 22q11.2 Deletion Syndrome	0
Strategy for Exercise Restriction in Hypertrophic Cardiomyopathy	0
Obesity Management for Patients with Coronary Artery Disease and Heart Failure	0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	0
The Economic Burden of Heart Failure with Reduced Ejection Fraction	0
Evaluation of Coronary Artery Disease and Ischemia by Cardiac Magnetic Resonance Imaging	0
Heart Failure with Reduced Ejection Fraction	0
Viability and Congestive Heart Failure	0
Positron Emission Tomography Imaging in Vasculitis	0
The Arrhythmic Phenotype in Cardiomyopathy	0
Interatrial Shunt Devices	0
Cardioprotection of High-Risk Individuals	0
Mildly Elevated Pulmonary Hypertension	0
Forthcoming Issues	0
Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan	0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology	0